Episode
AI, Decentralized Clinical Trials, and Paving the Way for New Technologies in Pharma: Marisa Co
- Podcast
- from Dreamers to Disruptors
- Published
- Jul 14, 2025
- Duration seconds
- 2903
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/from-dreamers-to-disruptors/2114603
Actions
POST https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/ai-decentralized-clinical-trials-and-paving-the-way-for-new-technologies-in-pharma-marisa-co/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/ai-decentralized-clinical-trials-and-paving-the-way-for-new-technologies-in-pharma-marisa-co.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Marisa Co has built a career based on intimate knowledge of every aspect of the pharmaceutical industry, giving her unparalleled insight into clinical trials and how to drive change in life sciences. Alongside senior roles at some of the biggest names in healthcare, her participation in the launch of Mytrus paved the way for decentralized clinical trials (DCTs). Join Marisa and Medidata CEO Anthony Costello as they dive into the technologies that enable DCTs to give patients ownership of their clinical trial journeys, and the AI boom that is transforming every aspect of clinical research. Marisa shares her unique insights into overcoming risk aversion within the clinical trials industry, and ensuring the successful adoption of game-changing technologies. She and Anthony dig into the progress of incorporating AI and eConsent into studies, and how to successfully deliver transformative change in healthcare. Visit our website Read our blog Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Marisa: LinkedIn